Day: December 11, 2019

WILMINGTON, Del., Dec. 11, 2019 (GLOBE NEWSWIRE) — InterDigital, Inc. (NASDAQ:IDCC), a mobile and video technology research and development company, today announced the appointment of two of its employees to the Board of Directors of MulteFire Alliance, an international consortium that advocates for the broad adoption of next generation mobile technologies in environments that use unlicensed and shared radio spectrum.MulteFire Alliance’s members have elected InterDigital’s Senior Director of Labs, Doug Castor, and Technical Staff Member, Muhammad Fazili, to serve as Full Director and Alternate Full Director, respectively. As representatives of InterDigital, the new directors will join board members from across the wireless technology industry, including representatives from Boingo, CableLabs, Ericsson, Huawei, Intel, Nokia, and...

San Francisco, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Oncology Pharma, Inc. (OTC: ONPH) announced today that it has signed a Letter of Intent (LOI) to acquire at least a 50% stake in Diagnomics, Inc., a private CLIA certified & CAP accredited private molecular Genomics lab in San Diego, CA (USA).   Included in the acquisition is Diagnomics’ partial of minority stake in EONE-Diagnomics Genome Center in Seoul South Korea.  EONE-Diagnomics was one of the most successful biotech IPOs (2018) on the KOSDAQ exchange. The LOI is the first step in Oncology Pharma’s initiative to build a strategic and growing presence in the global healthcare market.  The company is a founding member of the Illumina GSA consortium.  Diagnomics has pioneered an “intelligence drug development” platform that combines artificial intelligence...

3.15% Notes, Series CAA due February 19, 20303.95% Notes, Series CAB due February 16, 2050VANCOUVER, British Columbia, Dec. 11, 2019 (GLOBE NEWSWIRE) — TELUS announced today a dual-tranche offering (“the Offering”) of $600 million of senior unsecured Series CAA notes with a 10-year maturity and $400 million of senior unsecured Series CAB notes with a 30-year maturity. The notes are offered through a syndicate of agents led by CIBC World Markets Inc, Scotia Capital Inc. and TD Securities Inc. Closing of the Offering is expected to occur on or about December 16, 2019.The 3.15% 10-year Series CAA notes were priced at $99.649 per $100 principal amount for an effective yield of 3.190% per annum and will mature on February 19, 2030. The 3.95% 30-year Series CAB notes were priced at $99.154 per $100 principal amount for an effective yield...

Billets de série CAA assortis d’un taux de 3,15 % et arrivant à échéance le 19 février 2030Billets de série CAB assortis d’un taux de 3,95 % et arrivant à échéance le 16 février 2050VANCOUVER, Colombie-Britannique, 11 déc. 2019 (GLOBE NEWSWIRE) — TELUS annonce aujourd’hui une émission en deux tranches (l’« émission ») de 600 millions de dollars de billets non garantis de premier rang, série CAA, arrivant à échéance dans 10 ans, et de 400 millions de dollars de billets non garantis de premier rang, série CAB, arrivant à échéance dans 30 ans. Les billets sont offerts par l’intermédiaire d’un syndicat de placeurs dirigé par Marchés mondiaux CIBC inc., Scotia Capitaux Inc. et Valeurs Mobilières TD Inc. La clôture de cette émission est prévue le ou vers le 16 décembre 2019.Le prix des billets de série CAA assortis d’un taux de 3,15 %...

Maranello (Italy), 12 December 2019 – Ferrari N.V. (NYSE/MTA: RACE) (“Ferrari” or the “Company”) announces that it has signed on 11 December a Euro 350 million unsecured committed revolving credit facility, intended for general corporate and working capital purposes (the “New RCF”).The New RCF, entered into with a group of twelve banks, has a five-year tenor with two further one-year extension options, exercisable on the first and second anniversary of the signing date on Ferrari’s request and on each bank’s approval for its participation.This facility replaces the Euro 500 million committed revolving credit facility due November 2020, which has been cancelled.The New RCF provides a lower cost of capital as compared to the prior facility and confirms the support that Ferrari receives from a large panel of international key relashionship...

CALGARY, Alberta, Dec. 11, 2019 (GLOBE NEWSWIRE) — On December 2, 2019 Husky Energy (TSX:HSE) announced the fixed-rate quarterly dividend applicable to its Cumulative Redeemable Preferred Shares, Series 3 (Series 3 Shares) for the five-year period commencing December 31, 2019.The fixed-rate dividend for the Series 3 Shares announced on December 2, 2019 was calculated on November 29, 2019 as 4.636%, representing the sum of the Canadian Government five-year bond yield of 1.506% plus 3.13%.The new fixed-rate dividend for Series 3 Shares, based on a calculation as of December 2, 2019, is 4.689%, representing the sum of the Canadian Government five-year bond yield of 1.559% plus 3.13%.The dividend rate applicable to the Cumulative Redeemable Preferred Shares, Series 4 for the three-month period commencing December 31, 2019 to, but excluding,...

— Commodity Hedging Update —— Upcoming Conference Attendance —HOUSTON, Dec. 11, 2019 (GLOBE NEWSWIRE) — Penn Virginia Corporation (“Penn Virginia” or the “Company”) (NASDAQ:PVAC) today announced the Company’s completion of its fall borrowing base redetermination, increased commodity hedge position, and participation in upcoming investor conference.John A. Brooks, President and Chief Executive Officer of Penn Virginia commented, “Penn Virginia greatly appreciates the ongoing support from our lending group, and we are pleased that the banks reaffirmed their $500 million lending commitment to Penn Virginia. We believe that it is a testament to the Company’s high-quality asset base and financial strength.”Hedging UpdatePenn Virginia enters into oil hedges on a portion of its production to help mitigate commodity...

RICHMOND HILL, Ontario, Dec. 11, 2019 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced the start of enrollment and screening in the Company’s Phase lb/ll clinical development program for previously treated patients with advanced pancreatic cancer.The study is entitled “A Phase Ib/II Study of the Microenvironment Modifier L-DOS47 plus Doxorubicin for the Treatment of Patients with Previously Treated Advanced Pancreatic Cancer”.  The Phase Ib portion of the study involves three dose escalating cohorts enrolling a total of nine (9) patients.  The Phase II portion of the study will enroll an additional eleven (11) patients depending on meeting safety and efficacy criteria. ...

VANCOUVER, Washington, Dec. 11, 2019 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Nader Pourhassan, Ph.D., president and chief executive officer, will host an investment community conference call to provide an update on the Company.Date: Tuesday, December 17, 2019Time: 4:00 p.m. ET / 1:00 p.m. PTDial In: 877-407-2986 U.S. and Canada 201-378-4916 InternationalA live audio webcast may also be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 30 days. Web participants are encouraged to go to the website 15 minutes prior to the start of the call to register, download...

ST. JOHN’S, Newfoundland and Labrador, Dec. 11, 2019 (GLOBE NEWSWIRE) —It is with great sadness that Fortis acknowledges the passing of Ida J. Goodreau. Ida served as the Chair of the Governance and Nominating Committee of the Fortis Inc. Board of Directors and as Chair of the Board of Fortis subsidiary, FortisBC. Ida was a director of Fortis for a decade and served on the board of FortisBC and its predecessor for many years. A .pdf version of this press release is available at: http://ml.globenewswire.com/Resource/Download/f52d0609-e4fe-48cf-ae63-93d8a4cf48acFor more information contact